NCT05386667

Evaluation of the Effects of Medicaments Used After Free Gingival Graft on Postoperative Complications.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 60 (actual)
• Sponsor: Pamukkale University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

In our study, three different medicaments were evaluated in terms of postoperative complications after free gingival grafting (FGG).

Detailed description

In our study, three different medicaments were evaluated in terms of postoperative complications after free gingival grafting. The effectiveness of these 3 different commercially available agents containing flurbiprofen, hyaluronic acid, and hypochlorous acid, after use 2., 4.7. and on the 14th day, wound healing and pain perception was compared with the control group. primary observation was obtained by visual analog scale, wound healing index, bleeding of tissue, color match, and amount of painkiller used by the patient were also recorded

Conditions

• Pain, Postoperative
• Healing Wound
• Hemorrhage
• Analgesia

Interventions

Type	Name	Description
DRUG	Majezik %0.25 oral spray	Free gingival graft was taken from the palatal mucosa of the patients in order to increase the attached gingiva. After FGG, the patients were asked to apply this spray to the palatal mucosa 3 times a day.
OTHER	Aftamed oral spray	Free gingival graft was taken from the palatal mucosa of the patients in order to increase the attached gingiva. After FGG, the patients were asked to apply this spray to the palatal mucosa 3 times a day.
OTHER	Crystalin oral spray	Free gingival graft was taken from the palatal mucosa of the patients in order to increase the attached gingiva. After FGG, the patients were asked to apply this spray to the palatal mucosa 3 times a day.
PROCEDURE	Free gingival graft harvesting	Free gingival graft was taken from the palatal mucosa of the patients in order to increase the attached gingiva.

Timeline

• Start date: 2019-03-05
• Primary completion: 2022-03-15
• Completion: 2022-03-15
• First posted: 2022-05-23
• Last updated: 2022-05-23

Locations

1 site across 1 country: Turkey (Türkiye)

Regulatory

• FDA-regulated drug study